StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Shares Available for Future Grant Under Equity by Year

Shares Available for Future Grant Under Equity Incentive Plan (M shares) (M)

Amgen Shares Available for Future Grant Under Equity: 35M in FY2025, down 40.7% from a year earlier.

Latest, FY2025
35
Period ended Dec 31, 2025
Change on a year earlier
-40.7%
59 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Stock-Based Compensation Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShares Available for Future Grant Under Equity Incentive Plan (M shares) (M)Year on yearSource
FY2025Dec 31, 202535-40.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202459+391.7%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202312-20.0%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 202215-21.1%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 202119-17.4%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 202023-17.9%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 201928-12.5%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 201832-11.1%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 201736-12.2%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 201641-12.8%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 201547–Form 10-K (filed 2016-02-16) ↗

Cite this data

StockData. (2026). Amgen Shares Available for Future Grant Under Equity (M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/sbc-sh-avail

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.